03737.HK
Zhongzhi Pharmaceutical Holdings Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 0.63
−2.34%Year over year
Reported trailing growth
- Revenue
- -17.9%
- EBITDA
- -0.7%
- EBIT
- -59.2%
- EPS
- -9.4%
- Free cash flow
- -52.3%
- Operating cash flow
- -52.0%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -1.6%
- EBITDA
- -20.7%
- EBIT
- -64.1%
- Net income
- -45.4%
- EPS
- -46.0%
- Free cash flow
- -29.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026